2-二甲氨基乙基乙酸酯 | 1421-89-2

• 物质功能分类: 生物 - 细胞培养 - 添加剂
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-二甲氨基乙基乙酸酯
• 中文别名: 乙酸2-(二甲基氨基)乙酯；2-(二甲基氨基)乙基乙酸酯
• 英文名称: 2-(Dimethylamino)ethyl acetate
• 英文别名: noracetylcholine
• CAS: 1421-89-2
• 化学式: C₆H₁₃NO₂
• mdl: MFCD00041912
• 分子量: 131.175
• InChiKey: GOLSFPMYASLXJC-UHFFFAOYSA-N

物化性质

• 熔点：
  129-130 °C
• 沸点：
  152-154 °C
• 密度：
  0.92
• 闪点：
  47 °C
• 保留指数：
  1409
• 稳定性/保质期：
  如果遵照规格使用和储存，则不会分解，未有已知危险反应。应避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  3
• 危险品标志：
  Xn
• 安全说明：
  S16,S26,S36/37/39
• 危险类别码：
  R21/22,R10,R36/37/38
• RTECS号：
  AH2100000
• 海关编码：
  2922199090
• 包装等级：
  I; II; III
• 危险品运输编号：
  1993
• 储存条件：
  请将贮藏器保持密封，并存放在阴凉、干燥处。同时，确保工作环境有良好的通风或排气设施。

SDS

Name:	2-Dimethylaminoethyl Acetate Material Safety Data Sheet
Synonym:	Acetic Acid, 2-(Dimethylamino)Ethyl Ester; Dimethylaminoethanol Acetate
CAS:	1421-89-2

Section 1 - Chemical Product MSDS Name:2-Dimethylaminoethyl Acetate Material Safety Data Sheet
Synonym:Acetic Acid, 2-(Dimethylamino)Ethyl Ester; Dimethylaminoethanol Acetate

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1421-89-2	Acetic Acid, 2-(Dimethylamino)Ethyl Es	ca 100	215-827-4

Hazard Symbols: None Listed.
Risk Phrases: 10

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Flammable.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and corneal damage.
Skin:
May cause irritation and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated. Ingestion of large amounts may cause CNS depression.
Inhalation:
The toxicological properties of this substance have not been fully investigated. Aspiration may lead to pulmonary edema. Vapors may cause dizziness or suffocation. May cause burning sensation in the chest.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Vapors may form an explosive mixture with air.
Vapors can travel to a source of ignition and flash back. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Use water spray to keep fire-exposed containers cool. Water may be ineffective. Material is lighter than water and a fire may be spread by the use of water. Containers may explode in the heat of a fire.
Flammable liquid and vapor. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam. For large fires, use water spray, fog, or alcohol-resistant foam. Use water spray to cool fire-exposed containers. Water may be ineffective. Do NOT use straight streams of water.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Use a spark-proof tool. Provide ventilation. A vapor suppressing foam may be used to reduce vapors.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Ground and bond containers when transferring material. Use spark-proof tools and explosion proof equipment. Avoid contact with eyes, skin, and clothing. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Flammables-area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 1421-89-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 152.0 - 154.0 deg C
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 47 deg C ( 116.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9280g/cm3
Molecular Formula: C6H13NO2
Molecular Weight: 131.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1421-89-2: AH2100000 LD50/LC50:
Not available.
Carcinogenicity:
Acetic Acid, 2-(Dimethylamino)Ethyl Ester - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: FLAMMABLE LIQUID, N.O.S.*
Hazard Class: 3
UN Number: 1993
Packing Group: III
IMO
Shipping Name: FLAMMABLE LIQUID, N.O.S.
Hazard Class: 3.3
UN Number: 1993
Packing Group: III
RID/ADR
Shipping Name: FLAMMABLE LIQUID, N.O.S.
Hazard Class: 3
UN Number: 1993
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
R 10 Flammable.
Safety Phrases:
S 9 Keep container in a well-ventilated place.
S 16 Keep away from sources of ignition - No
smoking.
S 28A After contact with skin, wash immediately with
plenty of water.
S 33 Take precautionary measures against static
discharges.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1421-89-2: No information available.
Canada
CAS# 1421-89-2 is listed on Canada's DSL List.
CAS# 1421-89-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1421-89-2 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-二甲氨基乙基乙酸酯 在 双氧水 作用下， 以 异丙醇 为溶剂， 生成 2-(dimethylamino)ethyl acetate N-oxide
  参考文献：
  名称：

  PYROLYSIS OF DIMETHYLETHANOLAMINE OXIDE MONOHYDRATE

  摘要：

  不可用

  DOI：

  10.1139/v66-242
• 作为产物：
  描述：

  N,N-二甲基乙醇胺 在 sodium hydroxide 、 乙酸酐 作用下， 以 氯仿 为溶剂， 生成 2-二甲氨基乙基乙酸酯
  参考文献：
  名称：

  Dimethylamino derivatives and their use

  摘要：

  二甲氨基烷基)羧酸酯和-氨基甲酸酯以及(二甲氨基烷基)醚和脲是一种特别适用于作为聚环氧化合物的胺固化剂的化合物。它们赋予可固化混合物更长的固化时间，从而具有良好的加工性能，尤其是当这些混合物用作胶粘剂时。此外，机械性能通常也会得到改善。此外，由于这些化合物的挥发性低，因此在作为固化剂时具有优势。

  公开号：

  US04324739A1
• 作为试剂：
  描述：

  (E)-3-(8-Formyl-3-nitro-quinolin-6-yl)-acrylic acid butyl ester 在 sodium periodate 、 2-二甲氨基乙基乙酸酯 、 过碘酸 作用下， 生成
  参考文献：
  名称：

  硝基杂环还原是分子向药物输送至低氧细胞的分子内催化的范例。

  摘要：

  DOI：

  10.1021/jm00113a040

文献信息

• [EN] LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS<br/>[FR] LIPIDES ET COMPOSITIONS LIPIDIQUES POUR L'ADMINISTRATION DE PRINCIPES ACTIFS
  申请人：NOVARTIS AG

  公开号：WO2014136086A1

  公开（公告）日：2014-09-12

  This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1–R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.

  这项发明提供了一个式(I)的化合物，或其药用可接受的盐，其中R1-R4、L和X在此处被定义。式(I)的化合物及其药用可接受的盐是在将生物活性剂传递给细胞和组织中时有用的阳离子脂质。
• [EN] ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] COMPOSÉS DE TYPE ALCYNE EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHIONE RÉDUCTASE
  申请人：GLENMARK PHARMACEUTICALS SA

  公开号：WO2016055947A1

  公开（公告）日：2016-04-14

  Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

  提供的是式(Ia)的化合物及其药学上可接受的盐，其中A、B、R1、R2、m和n如本文所定义，这些化合物作为S-硝基谷胱甘肽还原酶(GSNOR)的抑制剂具有活性。这些化合物可以预防、抑制或抑制GSNOR的作用，因此在治疗GSNOR介导的疾病、疾病、综合征或病症方面具有用处，例如肺动脉高压、急性呼吸窘迫综合征(ARDS)、哮喘、支气管痉挛、咳嗽、肺炎、肺纤维化、间质性肺疾病、囊性纤维化和慢性阻塞性肺疾病(COPD)。
• QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS
  申请人：Wilson Dean

  公开号：US20080167305A1

  公开（公告）日：2008-07-10

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及作为电压门控钠通道抑制剂有用的化合物。该发明还提供了包括本发明化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病的方法。
• CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS
  申请人：POLYPHOR AG

  公开号：US20150051183A1

  公开（公告）日：2015-02-19

  The conformationally restricted, spatially defined macrocyclic ring system of formula (I) is constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. Macrocycles described by this ring system I are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), inhibitory activity on enzymes or antimicrobial activity. In particular, these macrocycles show inhibitory activity on endothelin converting enzyme of subtype 1 (ECE-1) and/or the cysteine protease cathepsin S (CatS), and/or act as antagonists of the oxytocin (OT) receptor, thyrotropin-releasing hormone (TRH) receptor and/or leukotriene B4 (LTB4) receptor, and/or as agonists of the bombesin 3 (BB3) receptor, and/or show antimicrobial activity against at least one bacterial strain. Thus they are showing great potential as medicaments for a variety of diseases.

  公式（I）的构象受限、空间定义的大环环系统由三个不同的分子部分组成：模板A、构象调节剂B和桥C。由这种环系统I描述的大环可通过并行合成或溶液中或固相上的组合化学轻松制造。它们被设计用于与各种特定生物靶标类相互作用，例如在G蛋白偶联受体（GPCR）上的激动或拮抗活性，酶的抑制活性或抗菌活性。特别是，这些大环显示对亚型1的内皮素转化酶（ECE-1）和/或半胱氨酸蛋白酶卡特普辛S（CatS）的抑制活性，和/或作为催产素（OT）受体、促甲状腺释放激素（TRH）受体和/或白三烯B4（LTB4）受体的拮抗剂，和/或作为瘤胃素3（BB3）受体的激动剂，和/或对至少一种细菌菌株显示抗菌活性。因此，它们显示出作为各种疾病药物的巨大潜力。
• Hydrogen-Bond Interactions of Nicotine and Acetylcholine Salts: A Combined Crystallographic, Spectroscopic, Thermodynamic and Theoretical Study
  作者：Virginie Arnaud、Michel Berthelot、Michel Evain、Jérôme Graton、Jean-Yves Le Questel

  DOI：10.1002/chem.200600808

  日期：2007.2.2

  experimental HB basicity of the cations despite its potential multisite HB acceptor properties. The preferred HB interaction site of the ammonium picrate salts was determined from a survey of crystallographic data found in the Cambridge Structural Database (CSD) and is supported by theoretical calculations. Two distinct classes of ammonium groups were characterised depending on the absence (quaternary ammonium)

  尼古丁和乙酰胆碱（ACh）的单电荷活性形式的氢键（HB）相互作用已通过使用密度泛函理论（DFT）计算从理论上进行了比较，并在晶体学观察和溶液中平衡常数的测量基础上进行了实验比较。尽管有潜在的多位HB受体特性，但使用2,4,6-三硝基苯酚（苦味酸）抗衡离子确定阳离子的实验HB碱性。根据在剑桥结构数据库（CSD）中发现的晶体学数据确定了优选的苦味酸铵HB相互作用位点，并得到了理论计算的支持。根据是否存在（季铵）或存在（三级，连接两个离子的N（+）HO氢键形成仲和伯铵盐）确定了烟酸烟碱的晶体结构，并将其与ACh进行了比较。该分析揭示了烟碱乙酰胆碱受体（nAChR）配体的铵部分对苦味酸根阴离子的特殊行为。已经开发出专用方法来分离阴离子和阳离子接受位点对溶液中测量的离子对的整体HB碱度的贡献。通过使用几种带有非碱性铵阳离子的模型离子对，在二氯甲烷溶液中测定了与两种不同铵类相关的苦味酸根阴离子的HB碱

表征谱图